Magrilan

Fluoxetine, the active ingredient in Magrilan, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It is prescribed for several mood‑related disorders and is indicated for adult patients who require serotonergic modulation. GNH USA supplies Magrilan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Fluoxetine acts on the serotonergic pathway and is approved for several psychiatric conditions. - Major depressive disorder: alleviates depressive symptoms and improves mood. - Obsessive‑compulsive disorder: reduces compulsive thoughts and repetitive behaviors. - Panic disorder: decreases frequency and intensity of panic attacks. - Bulimia nervosa: helps control binge‑eating and purging cycles. - Premenstrual dysphoric disorder: eases mood swings and physical symptoms associated with the menstrual cycle.

Fluoxetine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Insomnia: difficulty falling or staying asleep. - Headache: transient cranial discomfort. - Dry mouth: reduced salivation. - Diarrhea: loose stools or increased bowel movements. - Sexual dysfunction: decreased libido or delayed orgasm.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity, potentially life‑threatening. - Suicidal thoughts: emergence of suicidal ideation, especially in young adults. - Hyponatremia: low blood sodium causing confusion or seizures. - Severe allergic reaction: rash, swelling, or difficulty breathing.

Before initiating fluoxetine therapy, consider the following safety measures. - Pregnancy: discuss potential risks with a healthcare professional, as safety data are limited. - Breastfeeding: evaluate benefits versus possible infant exposure through milk. - History of bipolar disorder: monitor for mood switching to mania or hypomania. - Concomitant medications: review all current drugs for possible interactions. - Liver or kidney impairment: dose adjustment may be required based on clinical judgment. - Store below 25°C: keep in the original pack, protect from moisture.

Fluoxetine interacts with several drug classes; careful assessment is essential.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome if combined within 14 days. - Thioridazine or pimozide: can cause cardiac arrhythmias and QT prolongation.

Moderate Interactions (Monitor Closely): - Other serotonergic agents (e.g., tramadol, triptans): increased serotonin syndrome risk. - NSAIDs or anticoagulants: heightened bleeding tendency. - CYP2D6 inhibitors (e.g., quinidine, bupropion): may raise fluoxetine plasma levels.